首页> 外文期刊>BMC Nephrology >Total and corrected antioxidant capacity in hemodialyzed patients
【24h】

Total and corrected antioxidant capacity in hemodialyzed patients

机译:血液透析患者的总抗氧化能力和校正抗氧化能力

获取原文
           

摘要

Background Oxidative stress may play a critical role in the vascular disease of end stage renal failure and hemodialysis patients. Studies, analyzing either discrete analytes and antioxidant substances, or the integrated total antioxidant activity of human plasma during hemodialysis, give contradictory results. Methods Recently, we have introduced a new automated method for the determination of Total Antioxidant Capacity (TAC) of human plasma. We have serially measured TAC and corrected TAC (cTAC: after subtraction of the interactions due to endogenous uric acid, bilirubin and albumin) in 10 patients before the onset of the dialysis session, 10 min, 30 min, 1 h, 2 h and 3 h into the procedure and after completion of the session. Results Our results indicate that TAC decreases, reaching minimum levels at 2 h. However, corrected TAC increases with t1/2 of about 30 min. We then repeated the measurements in 65 patients undergoing dialysis with different filters (36 patients with ethylene vinyl alcohol copolymer resin filter -Eval-, 23 patients with two polysulfone filters -10 with F6 and 13 with PSN140-, and 6 patients with hemophan filters). Three specimens were collected (0, 30, 240 min). The results of this second group confirm our initial results, while no significant difference was observed using either filter. Conclusions Our results are discussed under the point of view of possible mechanisms of modification of endogenous antioxidants, and the interaction of lipid- and water-soluble antioxidants.
机译:背景技术氧化应激可能在终末期肾衰竭和血液透析患者的血管疾病中起关键作用。进行分析,分析离散分析物和抗氧化剂物质或血液透析过程中人血浆的综合总抗氧化剂活性的研究得出了矛盾的结果。方法最近,我们引入了一种测定人血浆总抗氧化能力(TAC)的自动化方法。我们在透析开始前10分钟,30分钟,1小时,2小时和3天,连续测量了10例患者的TAC并校正了TAC(cTAC:减去内源性尿酸,胆红素和白蛋白引起的相互作用后) h进入程序并完成会话。结果我们的结果表明TAC降低,在2 h达到最低水平。但是,校正后的TAC随着t 1/2 大约30分钟而增加。然后,我们对65例接受不同过滤器透析的患者(36例使用乙烯-乙烯醇共聚物树脂过滤器-Eval-的患者,23例两个聚砜过滤器-10,F6和13例PSN140-的患者以及6例血色素过滤器)进行了重复测量。收集了三个标本(0、30、240分钟)。第二组的结果证实了我们的初始结果,而使用两种过滤器均未观察到明显差异。结论我们从内源性抗氧化剂改性的可能机理以及脂类和水溶性抗氧化剂相互作用的角度讨论了我们的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号